Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene

Georg Stingl; E.‐B. Bröcker; Roland H. Mertelsmann; Kirsten Wolff; Susanne C. Schreiber; Eckhart Kämpgen; Achim Schneeberger; Jiri Trcka; U. Brennscheidt; Hendrik Veelken; Max L. Birnstiel; Kurt Zatloukal; Michael Buschle; Ernst-Rudolf Kempe; H. A. Weber; Thor Voigt

doi:10.1007/s001090050115

Enriched recordOpen access

Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene

Georg Stingl, E.‐B. Bröcker, Roland H. Mertelsmann, Kirsten Wolff, Susanne C. Schreiber, Eckhart Kämpgen, Achim Schneeberger, Jiri Trcka, U. Brennscheidt, Hendrik Veelken, Max L. Birnstiel, Kurt Zatloukal, Michael Buschle, Ernst-Rudolf Kempe, H. A. Weber, Thor Voigt

Journal of Molecular Medicine1997doi:10.1007/s001090050115

Citation graph

Abstract

No public abstract is available from the verified source records.

Authors

Georg Stingl#1 E.‐B. Bröcker#2 Roland H. Mertelsmann#3 Kirsten Wolff#4 Susanne C. Schreiber#5 Eckhart Kämpgen#6 Achim Schneeberger#7 Jiri Trcka#8 U. Brennscheidt#9 Hendrik Veelken

Referenced works

View all references →

No local reference links have been materialized yet.

Cited by

View all cited-by records →

No local citing links have been materialized yet.

External reference records

No reference metadata is available yet.

Additional external references

No additional external references are available.